NS · Healthcare

Balaxi Pharmaceuticals Ltd (BALAXI)

Pharmaceuticals & Biotechnology

Balaxi Pharmaceuticals Ltd (BALAXI) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.26B, P/E ratio is 24.31, net margin is 5.4%, dividend yield is 2.18%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BALAXI

Market cap

$1.26B

P/E ratio

24.31

Net margin

5.4%

Dividend yield

2.18%

Balaxi Pharmaceuticals Ltd (BALAXI) — FAQ

What is Balaxi Pharmaceuticals Ltd's market cap?

Balaxi Pharmaceuticals Ltd (BALAXI) has a reported market cap of $1.26B (data as of 2026-07-10).

What is BALAXI's P/E ratio?

The price-to-earnings (P/E) ratio for Balaxi Pharmaceuticals Ltd (BALAXI) is 24.31 (data as of 2026-07-10).

Does Balaxi Pharmaceuticals Ltd pay a dividend?

Balaxi Pharmaceuticals Ltd (BALAXI) shows a reported dividend yield of 2.18%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Balaxi Pharmaceuticals Ltd in?

Balaxi Pharmaceuticals Ltd (BALAXI) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is BALAXI listed on?

BALAXI is listed on NS.

What is Balaxi Pharmaceuticals Ltd's net margin?

Balaxi Pharmaceuticals Ltd (BALAXI) reports a net margin of 5.4% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)